Buy, sell, hold: 11 stocks that analysts are watching out today

Moneycontrol Bureau Here are 11 stocks that brokerage firms are watching out today.Indian pharma companies Nomura has a buy ratings on Dr Reddy’s, Glenmark, Alkem, Cadila and Jubilant Life. It says Teva’s 2017 guidanceis  lower than what was presented in 2016-2020 prelim outlook and implies a shortfall of USD 1.5-2 billion in EBITDA.Teva expects mid-single digit price erosion in the base US business. JP Morgan is overweight on Aurobindo Pharma with target at Rs 900 per share on valuation discount to large cap peers narrowed to over 30 percent. It says the stock may see re-rating from monetisation of strong pipeline for the US.

Info EdgeBank of America Merrill Lynch has downgraded it to neutral from buy on risks to earnings of recruitment, realty & Zomato business. It has also cut target by 7 percent to Rs 924 per share as headwinds in recruitment, 99acres & Zomato persist. It says Zomato’s valuation declines to USD 600-900  million, then Info Edge’s valuation will decline by 3-11 percent.

LupinCredit Suisse maintains underperform rating with target unchanged at Rs 1350 per share as it is likely to see less competition in Glumetza in the next two quarters.

Sadbhav Engineering Credit Suisse maintains outperform rating with target unchanged at Rs 375 per share as data suggests significant demonetisation impact on traffic. It says several projects have seen double-digit (13-17 percent) decline in December  in collection. It is positive on stock based on broad opportunity basket, expected improvement in traffic lower interest rates and healthy balancesheet.